Notably, continuous glucose monitoring showed a mean time-in-range increase to 88.9% under CagriSema ( vs 76.2% and 71.7%), and no serious hypoglycemia occurred (144)
*Correspondence: Roberta Poli, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Neither drugmaker provided any details about specific volumes
Now they're looking to understand their options for accessing these prescription weight loss peptides and whether the medications could work for their specific situation
Hours Advertisement Features American Express, Android Pay, Apple Pay, Cash, Check, Discover, Financing, Mastercard, Samsung Pay, Visa You might also like Also at this address Advertisement Advertisement Owner verified See a problem